Emerging Technologies Promise Revolutionary Diagnostic Tools
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read MorePosted by Elaine Sanchez Wilson | Apr 3, 2015 | Cancer, Heart Disease, Molecular Diagnostics |
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read MorePosted by Elaine Sanchez Wilson | Mar 27, 2015 | Emerging & Zoonotic Diseases, Infectious Diseases |
Delivering results in less than 2 hours, the Xpert ebola test has been authorized for use by CLIA moderate- and high-complexity laboratories or similarly qualified non-US laboratories.
Read MorePosted by Elaine Sanchez Wilson | Mar 23, 2015 | Infectious Diseases |
After three recent outbreaks of carbapenem-resistant Enterobacteriaceae cast a light on the dangers associated with multi-drug-resistant infections, Nanosphere recently reaffirmed the clinical benefits of its Verigene gram-negative blood culture test.
Read MorePosted by Elaine Sanchez Wilson | Mar 15, 2015 | Infectious Diseases, Sexually Transmitted Diseases |
Developed for small and medium-sized laboratories, the PelvoCheck CT/NG diagnostic kit from Greiner Bio-One is especially useful for reliably testing asymptomatic patients for Chlamydia trachomatis and Neisseria gonorrhoeae bacteria.
Read MorePosted by Steve Halasey | Mar 15, 2015 | Research |
The collaboration leverages grants from the Bill & Melinda Gates Foundation and Paul G. Allen Family Foundation to automate rapid ebola testing and increase access to reliable data from the field.
Read More